8512
الجريدة الرسمية عدد 6946 - 9 جمادى الأولى 1442 (24 ديسمبر 2020)
<ANTINEOPLASIQUES ET IMMUNOMODULATEURS
Injectable Injectable •• .
Injectable Injectable Injectable Injectable Injectable Injectable Injectable Injectable
Injectable Orale Injectable
Orale Orale Orale
Injectable Injectable Injectable Orale Orale Orale Orale Orale Orale Injectable •..
Injectable Injectable Injectable
K ANTINEOPLASIQUES CYTOTOXIQUES
25 mg/ml Aflibercept 000 10 U Asparaginase
400 mg Bevacizumab 25 mg Bendamustine 100 mg Bendamustine 1 mg Bortézomib 3,5 mg Bortézomib 60 mg / 1,5 mg Cabazitaxel 600 mg / 60 ml Carboplatine
5 mg/ ml Cetuximab
••. • • 80 mg Docetaxel 250 mg Gefitinib 160 mg/16 ml Docetaxel
100 mg Imatinib 400 mg Imatinib 200 mg Nilotinib
25 mg Mitoxantrone 1000 mg / 40 ml Obinutuzumab
50 mg Oxaliplatine 5 mg Phosphate de Ruxolitinib 15 mg Phosphate de Ruxolitinib 20 mg Phosphate de Ruxolitinib 75 mg Palbociclib 100 mg Palbociclib 125 mg Palbociclib 100 mg Oxaliplatine
440 mg Trastuzumab 600 mg / 5 ml Trastuzumab
0,1 mg Triptoreline
( بدون تغيير )